Glibenclamidelet and coronary artery disease Patient Reports February 12, 2012

Glibenclamidelet Side Effects Report #5577402-3
Glibenclamidelet side effect was reported by a Consumer or non-health professional from BRAZIL on Dec 18, 2007. Male patient was diagnosed with type 2 diabetes mellitus and was treated with Glibenclamidelet. After drug was administered, patient experienced the following side effects: coronary artery disease . Glibenclamidelet dosage: DAILY DOSE:25MG. During the same period patient was treated with GLYBURIDE, SIMVASTATIN, ATENOLOL, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.